Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.
N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.
PMID:24450891
Clinical and histopathological characteristics, diagnosis and treatment, and comorbidities of Bowen's disease: a retrospective study.
Zhou C, Jiang B, Zhang K, Wu J, Huang C, Xu N, Ye T, Chen B, Yu B, Zou Y, Shen C.
Front Med (Lausanne). 2023 Nov 15;10:1281540. doi: 10.3389/fmed.2023.1281540. eCollection 2023.
PMID:38034527
Multiple Bowen's disease due to long-term narrow-band ultraviolet B phototherapy: A case report and literature review.
Zhang D, Fan H, Liu X, Wang S, Lang X, Ma W, Pang Y.